rs149367557

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2

The NM_021098.3(CACNA1H):​c.5024G>A​(p.Arg1675Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000962 in 1,611,924 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1675L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000085 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000097 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

6
12
1

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 7.91

Publications

8 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BS2
High AC in GnomAd4 at 13 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.5024G>A p.Arg1675Gln missense_variant Exon 28 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.5024G>A p.Arg1675Gln missense_variant Exon 28 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.5039G>A p.Arg1680Gln missense_variant Exon 27 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.5042G>A p.Arg1681Gln missense_variant Exon 27 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.5006G>A p.Arg1669Gln missense_variant Exon 27 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.5039G>A p.Arg1680Gln missense_variant Exon 28 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.5024G>A p.Arg1675Gln missense_variant Exon 28 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.4985G>A p.Arg1662Gln missense_variant Exon 28 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.5006G>A p.Arg1669Gln missense_variant Exon 27 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.4967G>A p.Arg1656Gln missense_variant Exon 27 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.5024G>A p.Arg1675Gln missense_variant Exon 28 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.5006G>A p.Arg1669Gln missense_variant Exon 27 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.5024G>A p.Arg1675Gln missense_variant Exon 28 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.5024G>A p.Arg1675Gln missense_variant Exon 28 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.5024G>A p.Arg1675Gln missense_variant Exon 28 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.5024G>A non_coding_transcript_exon_variant Exon 28 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*976G>A non_coding_transcript_exon_variant Exon 27 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*105G>A non_coding_transcript_exon_variant Exon 28 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*2875G>A non_coding_transcript_exon_variant Exon 28 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*4468G>A non_coding_transcript_exon_variant Exon 26 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.5006G>A non_coding_transcript_exon_variant Exon 27 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.5006G>A non_coding_transcript_exon_variant Exon 27 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*25G>A non_coding_transcript_exon_variant Exon 28 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.5024G>A non_coding_transcript_exon_variant Exon 28 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.5024G>A non_coding_transcript_exon_variant Exon 28 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.5006G>A non_coding_transcript_exon_variant Exon 27 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.5024G>A non_coding_transcript_exon_variant Exon 28 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.5024G>A non_coding_transcript_exon_variant Exon 28 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.*25G>A non_coding_transcript_exon_variant Exon 27 of 35 ENSP00000518777.1
CACNA1HENST00000637236.3 linkn.*976G>A 3_prime_UTR_variant Exon 27 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*105G>A 3_prime_UTR_variant Exon 28 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*2875G>A 3_prime_UTR_variant Exon 28 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*4468G>A 3_prime_UTR_variant Exon 26 of 34 ENSP00000518758.1
CACNA1HENST00000711451.1 linkn.*25G>A 3_prime_UTR_variant Exon 28 of 36 ENSP00000518763.1
CACNA1HENST00000711488.1 linkn.*25G>A 3_prime_UTR_variant Exon 27 of 35 ENSP00000518777.1

Frequencies

GnomAD3 genomes
AF:
0.0000854
AC:
13
AN:
152152
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000123
AC:
30
AN:
244404
AF XY:
0.000120
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000203
Gnomad EAS exome
AF:
0.000561
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000154
Gnomad OTH exome
AF:
0.000168
GnomAD4 exome
AF:
0.0000973
AC:
142
AN:
1459654
Hom.:
0
Cov.:
32
AF XY:
0.000110
AC XY:
80
AN XY:
725914
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33438
American (AMR)
AF:
0.0000450
AC:
2
AN:
44480
Ashkenazi Jewish (ASJ)
AF:
0.000269
AC:
7
AN:
26044
East Asian (EAS)
AF:
0.000277
AC:
11
AN:
39656
South Asian (SAS)
AF:
0.0000233
AC:
2
AN:
85826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53120
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.000104
AC:
115
AN:
1111022
Other (OTH)
AF:
0.0000663
AC:
4
AN:
60300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000854
AC:
13
AN:
152270
Hom.:
0
Cov.:
33
AF XY:
0.0000806
AC XY:
6
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41558
American (AMR)
AF:
0.00
AC:
0
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5154
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68016
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000121
Hom.:
0
Bravo
AF:
0.000117
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.000191
AC:
23
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Nov 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1675 of the CACNA1H protein (p.Arg1675Gln). This variant is present in population databases (rs149367557, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with seizures (PMID: 27066544). This variant is also known as p.Arg1669Gln. ClinVar contains an entry for this variant (Variation ID: 571604). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CACNA1H protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Uncertain:1
Jun 15, 2023
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Identified in a patient with epilepsy with auditory features who inherited the variant from a parent with sleep-related bilateral tonic-clonic seizures (Pippucci et al., 2015); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27066544) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.64
BayesDel_addAF
Uncertain
0.049
T
BayesDel_noAF
Pathogenic
0.17
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.78
D;.;.;.
Eigen
Uncertain
0.60
Eigen_PC
Uncertain
0.53
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Pathogenic
0.99
D;D;D;.
M_CAP
Uncertain
0.28
D
MetaRNN
Uncertain
0.51
D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.0
M;.;.;.
PhyloP100
7.9
PrimateAI
Uncertain
0.70
T
PROVEAN
Uncertain
-3.9
D;.;D;D
REVEL
Pathogenic
0.80
Sift
Uncertain
0.0090
D;.;D;D
Sift4G
Uncertain
0.037
D;.;D;D
Polyphen
0.90
P;.;D;D
Vest4
0.69
MVP
0.96
ClinPred
0.40
T
GERP RS
4.0
Varity_R
0.72
gMVP
0.68
Mutation Taster
=29/71
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149367557; hg19: chr16-1265066; COSMIC: COSV61993376; COSMIC: COSV61993376; API